Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

At US FDA, Adding ‘Effective’ Staff For Overhauled OTC Monograph Program ‘Really Takes Time’

Sep 02 2020

• By Eileen Francis

Related Content

US FDA's Office Of New Drugs Reorganization Approved, But Not Happening Overnight

Sep 27 2019

'Real Challenge' To Improve OTC Monograph Program Without User Fees – FDA

Jun 16 2016

OTC Drug Oversight By US FDA Split Among Two Divisions In Reorganization

Jan 21 2020

US FDA Clarifies Testing In Sanitizer Production Temporary Guidances To Tighten Compliance

Aug 10 2020

US OTC Monograph Reform's Early Results Could Be Label Orders From FDA, Wait And See For Industry

Apr 16 2020

Exclusivity Period Allowed By OTC Monograph Reform Likely Up To Conference Committee

Jul 19 2018

Additional Topics

United States OTC Drugs FDA Commercial Advertising, Marketing & Sales Drug Approval Standards Ingredients Leadership Manufacturing Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window